Free Trial

6,389 Shares in DocuSign, Inc. (NASDAQ:DOCU) Purchased by APG Asset Management US Inc.

DocuSign logo with Computer and Technology background

APG Asset Management US Inc. purchased a new position in shares of DocuSign, Inc. (NASDAQ:DOCU - Free Report) during the 4th quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The fund purchased 6,389 shares of the company's stock, valued at approximately $575,000.

Other institutional investors and hedge funds have also modified their holdings of the company. Toronto Dominion Bank boosted its position in shares of DocuSign by 30.3% in the 3rd quarter. Toronto Dominion Bank now owns 26,159 shares of the company's stock worth $1,624,000 after buying an additional 6,081 shares in the last quarter. Rhumbline Advisers grew its position in shares of DocuSign by 118.8% in the fourth quarter. Rhumbline Advisers now owns 608,123 shares of the company's stock valued at $54,695,000 after purchasing an additional 330,136 shares during the last quarter. KBC Group NV increased its stake in shares of DocuSign by 32.7% during the 4th quarter. KBC Group NV now owns 1,535,107 shares of the company's stock worth $138,067,000 after purchasing an additional 378,233 shares in the last quarter. Jennison Associates LLC acquired a new position in shares of DocuSign during the 4th quarter worth approximately $12,897,000. Finally, Everence Capital Management Inc. acquired a new stake in DocuSign during the 4th quarter valued at $720,000. Institutional investors and hedge funds own 77.64% of the company's stock.

Wall Street Analysts Forecast Growth

A number of analysts recently commented on DOCU shares. Royal Bank of Canada reaffirmed a "sector perform" rating and set a $90.00 price objective on shares of DocuSign in a research note on Friday, March 14th. Citigroup upped their price objective on shares of DocuSign from $113.00 to $115.00 and gave the company a "buy" rating in a research note on Friday, March 14th. Jefferies Financial Group cut their price target on DocuSign from $115.00 to $105.00 and set a "buy" rating for the company in a report on Monday, March 31st. UBS Group lowered their price objective on DocuSign from $100.00 to $90.00 and set a "neutral" rating for the company in a research report on Friday, March 14th. Finally, Wells Fargo & Company raised their price target on DocuSign from $70.00 to $73.00 and gave the stock an "underweight" rating in a research note on Friday, March 14th. One analyst has rated the stock with a sell rating, eleven have given a hold rating and four have given a buy rating to the stock. According to MarketBeat, the company has a consensus rating of "Hold" and a consensus price target of $93.85.

View Our Latest Research Report on DOCU

DocuSign Stock Up 1.3 %

Shares of DOCU traded up $0.97 during midday trading on Tuesday, hitting $76.23. The company had a trading volume of 665,988 shares, compared to its average volume of 2,717,603. The company's 50 day moving average price is $82.52 and its 200 day moving average price is $82.99. DocuSign, Inc. has a 52 week low of $48.70 and a 52 week high of $107.86. The stock has a market cap of $15.44 billion, a price-to-earnings ratio of 15.72, a PEG ratio of 6.94 and a beta of 1.20.

DocuSign (NASDAQ:DOCU - Get Free Report) last issued its earnings results on Thursday, March 13th. The company reported $0.86 earnings per share for the quarter, topping the consensus estimate of $0.84 by $0.02. DocuSign had a return on equity of 14.90% and a net margin of 34.73%. The firm had revenue of $776.25 million for the quarter, compared to analyst estimates of $760.94 million. During the same period last year, the company earned $0.76 earnings per share. The firm's revenue for the quarter was up 9.0% on a year-over-year basis. Equities analysts anticipate that DocuSign, Inc. will post 1.17 EPS for the current fiscal year.

Insiders Place Their Bets

In related news, insider James P. Shaughnessy sold 7,500 shares of the stock in a transaction dated Tuesday, April 1st. The shares were sold at an average price of $81.31, for a total value of $609,825.00. Following the completion of the transaction, the insider now owns 45,875 shares in the company, valued at $3,730,096.25. This represents a 14.05 % decrease in their position. The sale was disclosed in a filing with the SEC, which is available at this hyperlink. Also, Director Teresa Briggs sold 534 shares of the company's stock in a transaction that occurred on Monday, March 17th. The stock was sold at an average price of $87.41, for a total transaction of $46,676.94. Following the completion of the sale, the director now directly owns 8,270 shares of the company's stock, valued at approximately $722,880.70. This represents a 6.07 % decrease in their ownership of the stock. The disclosure for this sale can be found here. In the last 90 days, insiders sold 47,851 shares of company stock worth $3,998,719. Insiders own 1.66% of the company's stock.

DocuSign Profile

(Free Report)

DocuSign, Inc provides electronic signature solution in the United States and internationally. The company provides e-signature solution that enables sending and signing of agreements on various devices; Contract Lifecycle Management (CLM), which automates workflows across the entire agreement process; Document Generation streamlines the process of generating new, custom agreements; and Gen for Salesforce, which allows sales representatives to automatically generate agreements with a few clicks from within Salesforce.

Featured Stories

Institutional Ownership by Quarter for DocuSign (NASDAQ:DOCU)

Should You Invest $1,000 in DocuSign Right Now?

Before you consider DocuSign, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and DocuSign wasn't on the list.

While DocuSign currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

7 AI Stocks to Invest in Today: Capitalizing on AI and Tech Trends in 2025 Cover

Discover the top 7 AI stocks to invest in right now. This exclusive report highlights the companies leading the AI revolution and shaping the future of technology in 2025.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

5 Blowout Earnings Winners That Could Soar Even Higher
5 Stocks You’ve Never Heard Of That I’m Buying Nonstop in 2025
3 Sectors With Massive Momentum You Can’t Afford to Miss

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines